Solution types used for immunogenicity mask assessment assay.
收藏数据链接：
官方服务：
资源简介：
Solution types used for immunogenicity mask assessment assay.
应用场景：
创建时间：
2022-11-21
相关数据集
Immunogenicity of Adalimumab in Patients with Non-Infectious Uveitis: Systematic Review and Meta-Analysis
To review the prevalence, incidence, and risk factors for developing anti-drug antibodies (AAA) in patients with non-infectious uveitis (NIU) treated with Adalimumab (ADA). A systematic literature sea
Taylor & Francis Group2024-09-24 更新50
Using serum metabolomics to predict development of anti-drug antibodies in multiple sclerosis patients treated with IFNβ
Hypothesis: Serum metabolomics can be used to predict immunogenicity against IFNβ in multiple sclerosis patients A prospective cohort of multiple sclerosis (MS) patients was recruited across six Euro
NIAID Data Ecosystem40
Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort
Besides anti-drug antibodies, anti-nuclear antibodies and anti-DNA antibodies are often induced in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. We examined the ass
Figshare2016-09-20 更新20
ADA occurrence during 12 months, stratified by disease and by BP therapy.
ADA, antidrug antibody; BP, biopharmaceutical product; IBD, inflammatory bowel disease; IFN, interferon; IL, interleukin; IM, intramuscular; MS, multiple sclerosis; RA, rheumatoid arthritis; SC, subcu
NIAID Data Ecosystem50
Table_1_Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells.docx
Pegylation of biopharmaceuticals is the most common strategy to increase their half-life in the blood and is associated with a reduced immunogenicity. As antigen presentation is a primary event in the
NIAID Data Ecosystem20
